74 results
10-K/A
2023 FY
ALLR
Allarity Therapeutics Inc
29 Apr 24
Annual report (amended)
4:06pm
The following table sets forth information concerning our executive officers, including their ages as of April 26, 2024.
Name | Year First Became Officer | Age | Position | |||
Thomas H. Jensen | 2023 | 45 | Chief Executive Officer | |||
Joan Y. Brown | 2022 | 70 | Chief Financial Officer | |||
Steen Knudsen, Ph.D. | 2021 | 62 | Chief Scientific Officer |
10-K/A
2023 FY
ALLR
Allarity Therapeutics Inc
29 Apr 24
Annual report (amended)
4:06pm
Board of Directors Diversity Matrix
Female | Male | |||||||
Part I: Gender Identity | ||||||||
Directors | 1 | 3 | ||||||
Part II: Demographic Background | ||||||||
African American or Black | 0 | 0 | ||||||
White | 1 | 3 |
10-K/A
2023 FY
ALLR
Allarity Therapeutics Inc
29 Apr 24
Annual report (amended)
4:06pm
The following table provides information regarding total compensation awarded to, earned by, and paid to our named executive officers as of December 31, 2023, for services rendered to the Company in all capacities for the fiscal years ended December 31, 2023 and 2022. No option awards were granted to our named executive officers under our 2021 Plan during the fiscal years ended December 31, 2023 and 2022.
Name and Principal Position | Year | Salary* | Bonus(1)* | All Other Compensation ($)* | Total* | |||||||||||||
Thomas H. Jensen(2) | 2022 | $ | — | $ | — | $ | — | $ | — | |||||||||
Chief Executive Officer, Corporate Secretary, and Senior Vice President, Investor Relations | 2023 | $ | — | $ | — | $ | 24,720 | (3) | $ | 24,720 | ||||||||
Joan Y. Brown | 2022 | $ | 180,000 | $ | — | — | $ | 180,000 | ||||||||||
Chief Financial Officer, Director of Financial Reporting | 2023 | $ | 250,000 | $ | — | — | $ | 250,000 | ||||||||||
Marie Foegh(4) | 2022 | $ | 340,309 | $ | — | — | $ | 340,309 | ||||||||||
Former Chief Medical Officer | 2023 | $ | 365,471 | $ | — | — | $ | 365,471 | ||||||||||
James G. Cullem, | 2022 | $ | 343,410 | $ | — | — | $ | 343,410 | ||||||||||
Former Chief Executive Officer and Former Chief Business Officer(5) | 2023 | $ | 405,492 | $ | 50,000 | $ | 68,320 | (6) | $ | 523,812 | ||||||||
Steen Knudsen | 2022 | $ | 372,426 | $ | — | — | $ | 372,426 | ||||||||||
Chief Scientific Officer | 2023 | $ | 266,215 | $ | — | — | $ | 266,215 |
10-K/A
2023 FY
ALLR
Allarity Therapeutics Inc
29 Apr 24
Annual report (amended)
4:06pm
As of the year ended December 31, 2023, we had an employment or consultancy agreement with each of the following named executive officers, Ms. Foegh and Ms. Brown. The employment or consultancy agreement with each of the following individuals provides for the initial annual base salary as of December 31, 2023, current base salary and bonus set forth below. With the departure of Mr. Cullem, the Board of Directors appointed Mr. Jensen to serve as the Chief Executive Officer of the Company, effective as of December 12, 2023, and a director of the Company. In connection with Mr. Jensen’s new position as Chief Executive Officer, the Company increased his consulting fees to $38,400 per month for an initial period of three months.
Named Executive Officers and Position | Annual Base Salary as of December 31, 2023 ($)* | |||
Thomas H. Jensen, Chief Executive Officer | $ | 460,800 | ||
James G. Cullem, Former Chief Executive Officer, Chief Business Officer(2) | $ | 350,000 | ||
Joan Y. Brown, Chief Financial Officer(3) and Director of Financial Reporting | $ | 250,000 | ||
Marie Foegh, Former Chief Medical Officer | $ | 331,200 |
10-K/A
2023 FY
ALLR
Allarity Therapeutics Inc
29 Apr 24
Annual report (amended)
4:06pm
The employment agreements with the following named executive officers provide for annual base salaries as set forth below. Compensation for Mr. Jensen is based on an hourly rate pursuant to his consultancy agreement as summarized above.
Named Executive Officers and Position | Annual Base Salary for the fiscal year ended December 31, 2023 ($)* | |||
Joan Y. Brown, Chief Financial Officer Director of Financial Reporting | $ | 250,000 | ||
Marie Foegh, Former Chief Medical Officer | $ | 339,480 | ||
Steen Knudsen, Chief Scientific Officer(1) | $ | 281,875 |
10-K/A
2ngkz9wlnugw0ulj
29 Apr 24
Annual report (amended)
4:06pm
10-K/A
ania2fa
29 Apr 24
Annual report (amended)
4:06pm
10-K/A
jn1cgg1
29 Apr 24
Annual report (amended)
4:06pm
10-K/A
nqmu5hfl
29 Apr 24
Annual report (amended)
4:06pm
10-K/A
ou67a8k
29 Apr 24
Annual report (amended)
4:06pm
10-K/A
sbt87f6
29 Apr 24
Annual report (amended)
4:06pm
10-K/A
6o16zvpg8bodaz6xe7lr
29 Apr 24
Annual report (amended)
4:06pm